Tablet Presentation

Each uncoated bilayer tablet contains:
Teneligliptin Hydrobromide Hydrate IP
Equivalent to Teneligliptin 20 mg
Metformin Hydrochloride  (as sustained release ) IP 500 mg

Diabetes may cause many complications and causes disability, reduces the quality of living and premature, this composition offers benefits and effectively treats short term and long-term complications.


In type-2 diabetes mellitus

About Composition


Teneligliptin is a dipeptidyl peptidase 4 inhibitor. It is used along with exercise and diet for the control of blood sugar level

Metformin Hydrochloride-

Metformin is a biguanide and it prevents the damage of kidney and blindness and problems in nerves, loss of limbs and sexual functional problems.

Mechanism of Action


It increases the release of insulin from the pancreas and causes the decrease in the release of hormone that raises the blood sugar levels.


It delays the absorption of glucose from the intestine and increases the sensitivity to insulin or lowers the production of glucose from liver.


Absorption- It is absorbed via GIT
Protein Binding- It is 90% bound to plasma proteins
Metabolism- It is metabolized in the liver
Excretion- It is excreted via urine

Side Effects

  • Nausea
  • Vomiting
  • Stomach upset
  • Sore throat
  • Congestion of nose


  • Contraindicated in people with renal impairment
  • Contraindicated in people with known hypersensitivity

Drug Interactions

  • Atenolol
  • Metoprolol
  • Vandetanib
Know About new DCGI Approved Products